Middle East & Africa Human Embryonic Stem Cells Market Size & Outlook
Middle East & Africa human embryonic stem cells market, 2018-2030 (US$M)
Related Markets
MEA human embryonic stem cells market highlights
- The MEA human embryonic stem cells market generated a revenue of USD 62.3 million in 2023.
- The market is expected to grow at a CAGR of 10.1% from 2024 to 2030.
- In terms of segment, regenerative medicine was the largest revenue generating application in 2023.
- Drug Discovery & Development is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 62.3 million |
| Market revenue in 2030 | USD 122.2 million |
| Growth rate | 10.1% (CAGR from 2023 to 2030) |
| Largest segment | Regenerative medicine |
| Fastest growing segment | Drug Discovery & Development |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Regenerative Medicine, Drug Discovery & Development |
| Key market players worldwide | Thermo Fisher Scientific Inc, Sartorius Stedim Biotech SA, Element Solutions Inc, PromoCell GmbH, Lonza Group Ltd, LifeCell International, Gilead Sciences Inc, International Stem Cell Corp |
Other key industry trends
- In terms of revenue, MEA region accounted for 4.4% of the global human embryonic stem cells market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 632.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Human Embryonic Stem Cells Market Scope
Human Embryonic Stem Cells Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa human embryonic stem cells market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to human embryonic stem cells market will help companies and investors design strategic landscapes.
Regenerative medicine was the largest segment with a revenue share of 90.21% in 2023. Horizon Databook has segmented the Middle East & Africa human embryonic stem cells market based on regenerative medicine, drug discovery & development covering the revenue growth of each sub-segment from 2018 to 2030.
Adoption of an intermediate national policy by the Muslim Middle East countries such as Turkey and Iran allows the use of existing hESC line for research purpose.
Existence of social, ethical and legal barriers to the use of hESC for research purpose has limited the growth of markets in these regions. Also, lack of funds, technology, and skilled personnel for the same is also significant reason for the restricted growth of the region.
Reasons to subscribe to Middle East & Africa human embryonic stem cells market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa human embryonic stem cells market databook
-
Our clientele includes a mix of human embryonic stem cells market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa human embryonic stem cells market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa human embryonic stem cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA human embryonic stem cells market size, by country, 2018-2030 (US$M)
Middle East & Africa Human Embryonic Stem Cells Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
